These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4468749)

  • 1. [Mouse teratocarcinoma: isolation and characterization of two muscle cell lines (author's transl)].
    Boon T; Buckingham ME; Dexter DL; Jakob H; Jacob F
    Ann Microbiol (Paris); 1974; 125B(1):13-28. PubMed ID: 4468749
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mouse teratocarcinoma: studies of antigens at the surface of multipotential cells (author's transl)].
    Dexter DL; Buc-Caron MH; Jakob H; Nicolas JF; Gachelin G
    Ann Microbiol (Paris); 1974; 125B(3):347-56. PubMed ID: 4142840
    [No Abstract]   [Full Text] [Related]  

  • 3. The isolation and properties of a clonal tissue culture strain of pluripotent mouse teratoma cells.
    Evans MJ
    J Embryol Exp Morphol; 1972 Aug; 28(1):163-76. PubMed ID: 4672577
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro growth and differetiation of clonal populations of multipotential mouse clls derived from a transplantable testicular teratocarcinoma.
    Rosenthal MD; Wishnow RM; Sato GH
    J Natl Cancer Inst; 1970 May; 44(5):1001-14. PubMed ID: 4936569
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mouse teratocarcinoma: cytogenetic studies of multipotential cells (author's transl)].
    Guénet JL; Jakob H; Nicolas JF; Jacob F
    Ann Microbiol (Paris); 1974; 125A(2):135-51. PubMed ID: 4473078
    [No Abstract]   [Full Text] [Related]  

  • 6. Developmental potentialities of clonal in vitro cultures of mouse testicular teratoma.
    Kahan BW; Ephrussi B
    J Natl Cancer Inst; 1970 May; 44(5):1015-36. PubMed ID: 5514468
    [No Abstract]   [Full Text] [Related]  

  • 7. A correlation between the capacity of cavity formation and the subsequent differentiation of teratocarcinoma embryoid body lines.
    Uno K
    J Embryol Exp Morphol; 1982 Jun; 69():127-40. PubMed ID: 6750025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tum- variants and the detection of tumor-specific transplantation antigens on spontaneous mouse tumors.
    Boon T; van Pel A; Uyttenhove C; Marchand M; Lambotte P
    Behring Inst Mitt; 1984 May; (74):209-13. PubMed ID: 6332616
    [No Abstract]   [Full Text] [Related]  

  • 9. Altered differentiation, indefinite growth potential, diminished tumorigenicity, and suppressed chimerization potential of hybrids between mouse teratocarcinoma cells and thymocytes.
    Martin GM; Ogburn CE; Au K; Disteche CM
    J Exp Pathol; 1984; 1(2):103-33. PubMed ID: 6599936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological criteria for the in vitro differentiation of embryoid bodies produced by a transplantable teratoma of mice.
    Teresky AK; Marsden M; Kuff EL; Levine AJ
    J Cell Physiol; 1974 Oct; 84(2):319-32. PubMed ID: 4474183
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of the teratocarcinoma phenotype in hybrids between totipotent mouse teratocarcinoma and myeloma cells.
    Correani A; Croce CM
    J Cell Physiol; 1980 Oct; 105(1):73-9. PubMed ID: 7430268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of SV40 tumor antigen in SV40 transformed teratocarcinoma-derived cell lines.
    Axelrod HR; Levine AJ
    J Cell Physiol; 1980 Aug; 104(2):249-52. PubMed ID: 6251099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a variant-producing tumor cell line from a heterogeneous strain BALB/cfC3H mouse mammary tumor.
    Hager JC; Fligiel S; Stanley W; Richardson AM; Heppner GH
    Cancer Res; 1981 Apr; 41(4):1293-300. PubMed ID: 6260334
    [No Abstract]   [Full Text] [Related]  

  • 14. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro.
    Andrews PW; Damjanov I; Simon D; Banting GS; Carlin C; Dracopoli NC; Føgh J
    Lab Invest; 1984 Feb; 50(2):147-62. PubMed ID: 6694356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of human transforming genes from chemically transformed, teratocarcinoma, and pancreatic carcinoma cell lines.
    Cooper CS; Blair DG; Oskarsson MK; Tainsky MA; Eader LA; Vande Woude GF
    Cancer Res; 1984 Jan; 44(1):1-10. PubMed ID: 6418375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Teratocarcinoma of the mouse: isolation, culture and properties of pluripotential cells].
    Jakob H; Boon T; Gaillard J; Nicolas J; Jacob F
    Ann Microbiol (Paris); 1973 Oct; 124(3):269-82. PubMed ID: 4599372
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunogenic cell variants of a mouse teratocarcinoma confer a protection against the original non-immunogenic transplantable tumor.
    Georlette M; Boon T
    Eur J Cancer Clin Oncol; 1981 Oct; 17(10):1083-7. PubMed ID: 7200017
    [No Abstract]   [Full Text] [Related]  

  • 18. Initiation and characterization of two porcine embryonal nephroma cell lines.
    Pirtle EC; Mengeling WL; Cheville NF
    Am J Vet Res; 1970 Sep; 31(9):1601-8. PubMed ID: 4097966
    [No Abstract]   [Full Text] [Related]  

  • 19. Formation of viable chimaeras by aggregation between teratocarcinomas and preimplantation mouse embryos.
    Stewart CL
    J Embryol Exp Morphol; 1982 Feb; 67():167-79. PubMed ID: 7086331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of the circulating antibodies to teratocarcinomadefined antigens in patients with testicular tumours.
    Teodorczyk-Injeyan J; Jewett MA; Burke CA; Ostrand-Rosenberg S
    Clin Exp Immunol; 1980 Jun; 40(3):438-44. PubMed ID: 6998614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.